NovaPoint Capital’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,175
Closed -$293K 133
2024
Q2
$293K Hold
3,175
0.1% 112
2024
Q1
$303K Sell
3,175
-1,480
-32% -$124K 0.11% 111
2023
Q4
$355K Sell
4,655
-1,100
-19% -$76.5K 0.13% 97
2023
Q3
$399K Sell
5,755
-191
-3% -$15.3K 0.16% 91
2023
Q2
$561K Hold
5,946
0.21% 84
2023
Q1
$492K Buy
5,946
+1
+0% +$79 0.2% 86
2022
Q4
$444K Hold
5,945
0.19% 89
2022
Q3
$491K Sell
5,945
-120
-2% -$11.5K 0.22% 89
2022
Q2
$577K Sell
6,065
-610
-9% -$63.1K 0.25% 81
2022
Q1
$786K Sell
6,675
-440
-6% -$49.4K 0.29% 70
2021
Q4
$922K Buy
7,115
+240
+3% +$28K 0.33% 69
2021
Q3
$778K Buy
6,875
+55
+0.8% +$6.28K 0.31% 69
2021
Q2
$706K Sell
6,820
-50
-0.7% -$4.71K 0.29% 69
2021
Q1
$575K Buy
6,870
+145
+2% +$12.3K 0.27% 70
2020
Q4
$614K Buy
6,725
+2,430
+57% +$202K 0.32% 66
2020
Q3
$343K Buy
+4,295
New +$335K 0.22% 70

Other funds holding EW